Skip to main content

WHO-ICMRA joint statement on the need for improved global regulatory alignment on COVID-19 medicines and vaccines

In November, ICMRA and the World Health Organization (WHO) committed to working together to ensure that patients have access to safe and effective medicines against COVID-19 as early as possible, while the existing rigorous scientific standards for the evaluation and safety monitoring of treatments and vaccines are maintained at all times.

WHO-ICMRA joint statement on the need for improved global regulatory alignment on COVID-19 medicines and vaccines (6 November 2020)

In their joint statement, ICMRA members and WHO:

  • reiterate that therapeutics and vaccines against COVID-19 can only be rapidly approved if applications are supported by robust and sound scientific evidence that allows medicine regulators to conclude on a positive benefit-risk balance for these products;
  • pledge to take concrete actions to ensure equitable access to safe, effective and quality-assured medicines for the treatment or prevention of COVID-19 around the world.

 

Statement in other languages